Web Stats Provided By Google Analytics

Thursday, January 23, 2014

CytRx begins Phase 2 clinical trial with aldoxorubicin for Kaposi's sarcoma

CytRx begins Phase 2 clinical trial with aldoxorubicin for Kaposi's sarcoma CytRx has initiated a Phase 2 clinical trial to determine preliminary efficacy and safety of aldoxorubicin for HIV-infected patients with Kaposi's sarcoma.

http://ift.tt/KKLYP1
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Healthcare Law Roundup Posts